Signal transduction pathways and mechanisms of apoptosis in CLL B- lymphocytes: Their role in CLL pathogenesis

Hematology and Cell Therapy

Volumn 39, Issue SUPPL. 1, 1997, Pages

  Kipps, T J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Apoptosis, and the bcl2 family of proteins; Immunoglobulin genes; Immunoglobulin repertoires; Signal transduction

Indexed keywords

CD5 ANTIGEN; PROTEIN BCL 2;

ANTIGEN RECOGNITION; APOPTOSIS; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; CROSS LINKING; HUMAN; LEUKEMOGENESIS; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

APOPTOSIS; B-LYMPHOCYTES; HUMANS; LEUKEMIA, B-CELL, CHRONIC; SIGNAL TRANSDUCTION;

EID: 0031422499     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-997-0017-4     Document Type: Conference Paper

References (41)

1. Brezinschek HP, Brezinschek RI, Lipsky PE (1995) Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 155: 190-202
2. Brezinschek HP, Foster SJ, Brezinschek RI, et al. (1997) Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest 99: 2488-2501
3. Clark EA (1993) CD22, a B cell-specific receptor, mediates adhesion and signal transduction. J Immunol 150: 4715-4718
4. Clark EA (1997) Regulation of B lymphocytes by dendritic cells [comment]. J Exp Med 185: 801-803
5. Clark EA, Hynes RO (1996) Ras activation is necessary for integrin-mediated activation of extracellular signal-regulated kinase 2 and cytosolic phospholipase A2 but not for cytoskeletal organization. J Biol Chem 271: 14814-14818
6. Clark EA, Law CL (1995) Immune accessory molecules and signal transduction. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds) Williams hematology. McGraw-Hill, New York, p. 946-955
7. Clark EA, Ledbetter JA (1994) How B and T cells talk to each other. Nature 367: 425-428
8. Devereaux QL, Takahashi R, Salvesen GS, et al. (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304
9. Domiati-Saad R, Attrep JF, Berzinschek HP, et al. (1996) Staphylococcal enterotoxin D functions as a human B cell superantigen by rescuing VH4-expressing B cells from apoptosis. J Immunol 156: 3608-3620
10. Domiati-Saad R, Lipsky PE (1997) B cell superantigens: potential modifiers of the normal human B cell repertoire. Int Rev Immunol 14: 309-324
11. Dorner T, Brezinschek HP, Brezinschek RI, et al. (1997) Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol 158: 2779-2789
12. Foster SJ, Brezinschek HP, Brezinschek RI, et al. (1997) Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest 99: 1614-1627
13. Graves JD, Draves KE, Craxton A, et al. (1996) Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci USA 93:13814-13818
14. Johnson TA, Rassenti LZ, Kipps TJ (1997) Ig VH1 genes expressed in B-cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 158: 235-246
15. Jurgensmeier JM, Krajewski S, Armstrong RC, et al. (1997) Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe. Mol Biol Cell 8: 325-339
16. Kipps TJ (1997) Human B cell biology. Intern Rev Immunol 15:243-264
17. Kipps TJ, Tomhave E, Chen PP, Carson DA (1988) Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy. J Exp Med 167:840-852
18. Kipps TJ, Tomhave E, Pratt LF, et al. (1989) Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 86: 5913-5917
19. Kohsaka H, Carson DA, Rassenti LZ, et al. (1996) The human immunoglobulin V(H) gene repertoire is genetically controlled and unaltered by chronic autoimmune stimulation. J Clin Invest 98: 2794-2800
20. Law CL, Aruffo A, Chandran KA, et al. (1995) Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J Immunol 155: 3368-3376
21. Law CL, Chandran KA, Sidorenko SP, et al. (1996) Phospholipase C-gammal interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol 16: 1305-1315
22. Law CL, Sidorenko SP, Chandran KA, et al. (1994) Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J Biol Chem 269: 12310-12319
23. Law CL, Sidorenko SP, Chandran KA, et al. (1996) CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation. J Exp Med 183: 547-560
24. Law CL, Sidorenko SP, Clark EA (1994) Regulation of lymphocyte activation by the cell-surface molecule CD22. Immunol Today 15: 442-449
25. Leprince C, Draves KE, Geahlen RL, et al. (1993) CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci USA 90: 3236-3240
26. Li L, Krajewski S, Reed JC, et al. (1997) The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression. Cell Immunol 178: 33-41
27. Lomo J, Blomhoff HK, Jacobsen SE, et al. (1997) Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 89: 4415-4424
28. Lomo J, Smeland EB, Krajewski S, et al. (1996) Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res 56: 40-43
29. Miyashita T, Mami U, Inoue T, et al. (1997) Bcl-2 relieves the transrepressive function of the glucocorticoid receptor and inhibits the activation of CPP32-like cysteine proteases. Biochem Biophys Res Commun 233: 781-737
30. Otipoby KL, Andersson KB, Draves KE, et al. (1996) CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384: 634-637
31. Rassenti LZ, Kipps TJ (1997) Lack of Allelic Exclusion in B cell chronic lymphocytic leukemia. J Exp Med 185: 1435-1445
32. Rassenti LZ, Kohsaka H, Kipps TJ (1995) Analysis of immunoglo-bulin VH gene repertoire by an anchored PCR-ELISA. Ann NY Acad Sci 764: 463-473
33. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776
34. Reed JC, Zha H, Aime-Sempe C, et al. (1996) Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. Adv Exp Med Biol 406: 99-112
35. Sasso EH, Johnson T, Kipps TJ (1996) Expression of the Ig VH gene 51p1 is proportional to its germline gene copy number. J Clin Invest 97: 2074-2080
36. Schendel SL, Xie Z, Montai MO, et al. (1997) Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 94: 5113-5118
37. Sidorenko SP, Law CL, Chandran KA, et al. (1995) Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein. Proc Natl Acad Sci USA 92: 359-363
38. Sidorenko SP, Law CL, Klaus SJ, et al. (1996) Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity 5: 353-363
39. Thomas A, el Rouby S, Reed JC, et al. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 12: 1055-1062
40. Wang HG, Rapp UR, Reed JC (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria [see comments]. Cell 87: 629-638
41. Wang HG, Takayama S, Rapp UR, et al. (1996) Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 93: 7063-7068